Andrea Tan
Stock Analyst at Goldman Sachs
(1.92)
# 3,010
Out of 4,753 analysts
39
Total ratings
40%
Success rate
-8.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $36 → $41 | $56.88 | -27.91% | 3 | Nov 15, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $80.50 | +26.71% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $5.02 | +19.64% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $20.19 | +53.58% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.35 | +471.59% | 3 | Jun 5, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $19 → $21 | $5.96 | +252.64% | 4 | Feb 29, 2024 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $50 → $44 | $12.22 | +260.07% | 4 | Feb 27, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $5.81 | -65.59% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $163.75 | -2.29% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.32 | +622.89% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.42 | +182.69% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $338.56 | +10.76% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $8.68 | +49.77% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $1.45 | +176.82% | 2 | May 24, 2022 |
Tarsus Pharmaceuticals
Nov 15, 2024
Maintains: Neutral
Price Target: $36 → $41
Current: $56.88
Upside: -27.91%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $80.50
Upside: +26.71%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $5.02
Upside: +19.64%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $20.19
Upside: +53.58%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.35
Upside: +471.59%
Iovance Biotherapeutics
Feb 29, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $5.96
Upside: +252.64%
Day One Biopharmaceuticals
Feb 27, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $12.22
Upside: +260.07%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $5.81
Upside: -65.59%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $163.75
Upside: -2.29%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.32
Upside: +622.89%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.42
Upside: +182.69%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $338.56
Upside: +10.76%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $8.68
Upside: +49.77%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $1.45
Upside: +176.82%